Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02756507
Other study ID # PN-II-PT-PCCA-2011-3.1-1500
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2016
Est. completion date June 2018

Study information

Verified date February 2023
Source Babes-Bolyai University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Anxiety and depressive disorders are common in adolescents, however they are often unrecognized. Rational emotive behavioral therapy (REBT), a form of cognitive behavioral therapy (CBT) is efficient for children and adolescents. School settings are appropriate environments to deliver such interventions for vulnerable youths. Given youth's access and predilection to use technology, a video-based prevention program was developed. The present study aims to investigate the efficacy of a transdiagnostic REBT prevention program for internalizing symptoms in adolescents, implemented in a school setting. Classes from different Romanian public schools will be randomized in either intervention or wait list group.


Description:

The prevention program will be group-based, delivered in 6 sessions, over 3 weeks. Each of the six modules aimed a different component: Psychoeducation, Relaxation, Relationship between cognitive distortions/irrational beliefs and emotions, Cognitive restructuring, Exposure/ behavioral activation and problem solving, Maintenance of gainings. Despite specific activities, for each session a video cartoon on that subject will be viewed and discussed. Homework would be given at every session. REBT prevention programs delivered in school settings represent ecological modalities to target vulnerable groups. Technology components added to traditional programs may lead to greater motivation and satisfaction with treatment. Adolescents will complete assessments at four time-points: T1 (baseline), T2 (post-intervention), T3 (3 months follow-up) and T4 (12 months follow-up).


Recruitment information / eligibility

Status Completed
Enrollment 381
Est. completion date June 2018
Est. primary completion date June 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 17 Years
Eligibility Inclusion Criteria: 1. Preadolescents and adolescents will have ages between 12 and 17 years old; 2. Are attending middle school or high-school; 3. Adolescents have sufficient understanding of the Romanian language in order to complete assessments at all time points and to participate in the prevention program; 4. Their parents have sufficient understanding of the Romanian language in order to sign the informed consent; 5. Parents will sign the informed consent and adolescents will provide informed assent. Exclusion Criteria: 1. Age below 14 or above 17 years; 2. No signed informed consent from parents; 3. Adolescents will score high on suicidal ideation according to (1 item on the Depression subscale from Beck Youth Inventories); 4. Not Romanian-speaking in order to understand the content of the prevention program and to complete the assessments.

Study Design


Intervention

Behavioral:
video-based transdiagnostic REBT
The video-based transdiagnostic REBT consists of 6 sessions delivered in a group format.
Wait list
Delayed intervention

Locations

Country Name City State
Romania Babes-Bolyai University Cluj-Napoca

Sponsors (1)

Lead Sponsor Collaborator
Babes-Bolyai University

Country where clinical trial is conducted

Romania, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, Stallings, & Conners, 1997) anxiety symptoms Change from baseline anxiety symptoms at 3 weeks post-intervention, 3 months follow up, 12 months follow-up
Primary Beck Depression Inventory for Youth subscale from the Beck Youth Inventories-Second edition for children and adolescents (Beck, 2005) depressive symptoms Change from baseline depressive symptoms at 3 weeks post-intervention, 3 months follow up, 12 months follow-up
Secondary The Children's Automatic Thoughts Scale - Negative/Positive (CATS-N/P) (Hogendoorn et al., 2010) maladaptive cognitions Change from baseline maladaptive cognitions at 3 weeks post-intervention, 3 month follow up, 12 months follow-up
Secondary The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1997) comorbid problems Change from baseline comorbid problems at 3 weeks post-intervention, 3 months follow up, 12 months follow-up
Secondary The Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents, The Revised Version - adolescent version (Kiddo-KINDL) (Ravens-Sieberer et al., 2001) quality of life Change from baseline quality of life at 3 weeks post-intervention, 3 months follow up, 12 months follow-up
Secondary The Credibility/ Expectancy Questionnaire (Devilly & Borkovec, 2000) Treatment expectancies pre-intervention
Secondary The Client Satisfaction Scale (Vigerland et al., 2016) Satisfaction with the intervention post-intervention
See also
  Status Clinical Trial Phase
Terminated NCT03420456 - Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Withdrawn NCT02382224 - Worry Exposure for Generalized Anxiety Disorder N/A
Completed NCT02306356 - Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting N/A
Completed NCT02256566 - Cognitive Training for Mood and Anxiety Disorders N/A
Completed NCT01958788 - Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder N/A
Completed NCT01681329 - Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder N/A
Completed NCT01201967 - A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients Phase 4
Completed NCT01342120 - PHARMO Institute Seroquel Safety Study N/A
Completed NCT01337713 - Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD) N/A
Completed NCT01971203 - Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat N/A
Completed NCT00961298 - An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder Phase 4
Completed NCT01203293 - Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector Phase 1
Completed NCT00744627 - Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. Phase 3
Terminated NCT01244711 - Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines Phase 4
Completed NCT00711737 - Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months N/A
Completed NCT00515242 - Therapeutic Massage for Generalized Anxiety Disorder Phase 1/Phase 2
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00537615 - An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers Phase 1
Completed NCT00620776 - Combined Treatment for Generalized Anxiety Disorder (GAD) Phase 2